Hospitalization and mortality of patients with systemic lupus erythematosus

Journal of Rheumatology

Volumn 33, Issue 9, 2006, Pages 1770-1774

  Krishnan, Eswar ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Hospitalization; Mortality; Systemic lupus erythematosus

Indexed keywords

ADULT; AGED; ARTICLE; CORRELATION ANALYSIS; FEMALE; HEALTH CARE COST; HOSPITAL ADMISSION; HOSPITAL CHARGE; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; INCOME; LENGTH OF STAY; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOMES RESEARCH; PRIORITY JOURNAL; PRIVATE HEALTH INSURANCE; SOCIOECONOMICS; SYSTEMIC LUPUS ERYTHEMATOSUS; UNITED STATES;

AGE DISTRIBUTION; FEMALE; HEALTH CARE COSTS; HOSPITALIZATION; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEX DISTRIBUTION; SURVIVAL RATE; UNITED STATES;

EID: 33748553360     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Borchers AT, Keen CL, Shoenfeld Y, Gershwin ME. Surviving the butterfly and the wolf: mortality trends in systemic lupus erythematosus. Autoimmun Rev 2004;3:423-53.
2. Trager J, Ward MM. Mortality and causes of death in systemic lupus erythematosus. Curr Opin Rheumatol 2001;13:345-51.
3. Edwards CJ, Lian TY, Badsha H, Teh CL, Arden N, Chng HH. Hospitalization of individuals with systemic lupus erythematosus: characteristics and predictors of outcome. Lupus 2003;12:672-6.
4. Petri M, Genovese M. Incidence of and risk factors for hospitalizations in systemic lupus erythematosus: a prospective study of the Hopkins Lupus Cohort. J Rheumatol 1992;19:1559-65.
5. Steiner C, Elixhauser A, Schnaier J. The healthcare cost and utilization project: an overview. Eff Clin Pract 2002;5:143-51.
6. Hart AC, Hopkins C. ICD-9 CM professional for physicians. 6th ed. Salt Lake City, UT: Ingenix; 2004.
7. Keiding N, Klein JP, Horowitz MM. Multi-state models and outcome prediction in bone marrow transplantation. Stat Med 2001;20:1871-85.
8. Yin G, Cai J. Quantile regression models with multivariate failure time data. Biometrics 2005;61:151-61.
9. Ward MM. Hospital experience and mortality in patients with systemic lupus erythematosus: which patients benefit most from treatment at highly experienced hospitals? J Rheumatol 2002;29:1198-206.
10. Madden J. Acute disseminated lupus erythematosus. Arch Dermatol Syph 1932;12:951-63.
11. Cook CD, Wedgwood RJ, Craig JM, Hartmann JR, Janeway CA. Systemic lupus erythematosus. Description of 37 cases in children and a discussion of endocrine therapy in 32 of the cases. Pediatrics 1960;26:570-85.
12. Petri M, Perez-Gutthann S, Longenecker JC, Hochberg M. Morbidity of systemic lupus erythematosus: role of race and socioeconomic status. Am J Med 1991;91:345-53.
13. Rask KJ, Williams MV, Parker RM, McNagny SE. Obstacles predicting lack of a regular provider and delays in seeking care for patients at an urban public hospital. JAMA 1994;271:1931-3.